{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T14:26:56Z","timestamp":1780583216192,"version":"3.54.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009601","name":"Beijing Municipal Administration of Hospitals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.clinthera.2021.01.013","type":"journal-article","created":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T18:53:15Z","timestamp":1614106395000},"page":"602-612","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Frequency and Patterns of Prescribing Antihypertensive Agents in Outpatient Kidney Transplant Recipients Among Six Cities in China from 2011 to 2018"],"prefix":"10.1016","volume":"43","author":[{"given":"Wenjing","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4992-6659","authenticated-orcid":false,"given":"Anqi","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiping","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2021.01.013_bib1","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1681\/ASN.2014080834","article-title":"Assessment and management of hypertension in transplant patients","volume":"26","author":"Weir","year":"2015","journal-title":"J\u00a0Am Soc Nephrol : JASN"},{"key":"10.1016\/j.clinthera.2021.01.013_bib2","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1681\/ASN.2013040435","article-title":"BP, cardiovascular disease, and death in the folic acid for vascular outcome reduction in transplantation trial","volume":"25","author":"Carpenter","year":"2014","journal-title":"J\u00a0Am Soc Nephrol : JASN"},{"key":"10.1016\/j.clinthera.2021.01.013_bib3","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1111\/j.1600-6143.2005.01093.x","article-title":"Improved long-term outcomes after renal transplantation associated with blood pressure control","volume":"5","author":"Opelz","year":"2005","journal-title":"Am J Transplant : official J Am Soc Transplant Am Soc Transpl Surgeons"},{"key":"10.1016\/j.clinthera.2021.01.013_bib4","first-page":"112","article-title":"Guideline on hypertension management of recipients with organ transplantation in China (2019 edition)","volume":"10","year":"2019","journal-title":"Organ Transpl"},{"key":"10.1016\/j.clinthera.2021.01.013_bib5","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/CRD.0000000000000126","article-title":"Hypertension in the kidney transplant recipient: overview of pathogenesis, clinical assessment, and treatment","volume":"25","author":"Glicklich","year":"2017","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.clinthera.2021.01.013_bib6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00059-016-4431-7","article-title":"Patterns of antihypertensive medication use in kidney transplant recipients","volume":"42","author":"Divac","year":"2017","journal-title":"Herz"},{"key":"10.1016\/j.clinthera.2021.01.013_bib7","doi-asserted-by":"crossref","first-page":"50","DOI":"10.12659\/AOT.882636","article-title":"Prevalence of arterial hypertension and the number and classes of antihypertensive drugs prescribed for patients late after kidney transplantation","volume":"17","author":"Kurnatowska","year":"2012","journal-title":"Ann Transplant"},{"key":"10.1016\/j.clinthera.2021.01.013_bib8","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.transproceed.2012.05.089","article-title":"Blood pressure control according to the prevalence of diabetes in renal transplant recipients","volume":"45","author":"Zbroch","year":"2013","journal-title":"Transplant Proc"},{"key":"10.1016\/j.clinthera.2021.01.013_bib9","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults","volume":"71","author":"Whelton","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.clinthera.2021.01.013_bib10","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/ndt\/gfz092","article-title":"Comparative effectiveness of different antihypertensive agents in kidney transplantation: a systematic review and meta-analysis","volume":"35","author":"Pisano","year":"2020","journal-title":"Nephrol Dialysis, Transplantation: Official Publication Eur Dial Transpl Assoc - Eur Ren Assoc"},{"key":"10.1016\/j.clinthera.2021.01.013_bib11","first-page":"337","article-title":"KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease","volume":"2","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.clinthera.2021.01.013_bib12","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The Seventh report of the Joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report","volume":"21","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2021.01.013_bib13","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s11096-012-9626-2","article-title":"Management of hypertension and factors affecting its control in Jordanian renal transplant recipients","volume":"34","author":"Bulatova","year":"2012","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.clinthera.2021.01.013_bib14","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.transproceed.2014.12.009","article-title":"Number of antihypertensive drugs at 1 year after kidney transplantation","volume":"47","author":"Kislikova","year":"2015","journal-title":"Transplant Proc"},{"key":"10.1016\/j.clinthera.2021.01.013_bib15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000486905","article-title":"Treatment of hypertension in renal transplant recipients in four independent cross-sectional analyses","volume":"43","author":"Ku\u017amiuk-Glembin","year":"2018","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.clinthera.2021.01.013_bib16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.transproceed.2017.11.023","article-title":"Improvement of blood pressure control in renal transplant recipients-retrospective longitudinal study","volume":"50","author":"Adrych","year":"2018","journal-title":"Transplant Proc"},{"key":"10.1016\/j.clinthera.2021.01.013_bib17","first-page":"258","article-title":"Treatment efficacy of hypertension in kidney transplant recipients in The Netherlands","volume":"72","author":"Dobrowolski","year":"2014","journal-title":"Neth J Med"},{"key":"10.1016\/j.clinthera.2021.01.013_bib18","unstructured":"Chinese Medical Association (CMA). Report on Organ Transplantation Development in China (2015\u20132018) (CMA Website). Available at: http:\/\/en.cma.org.cn\/art\/2020\/5\/14\/art_688_34499.html."},{"key":"10.1016\/j.clinthera.2021.01.013_bib19","doi-asserted-by":"crossref","first-page":"430","DOI":"10.5414\/CP202243","article-title":"Trends and patterns of five antihypertensive drug classes between 2007 and 2012 in China using hospital prescription data","volume":"53","author":"Xu","year":"2015","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2021.01.013_bib20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/nep.12168","article-title":"Commentary on the KDIGO Clinical Practice Guideline for the management of blood pressure in chronic kidney disease","volume":"19","author":"Roberts","year":"2014","journal-title":"Nephrology (Carlton, Vic)"},{"key":"10.1016\/j.clinthera.2021.01.013_bib21","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1053\/j.ajkd.2013.03.018","article-title":"KDOQI US commentary on the 2012 KDIGO clinical practice guideline for management of blood pressure in CKD","volume":"62","author":"Taler","year":"2013","journal-title":"Am J kidney Dis: official J Natl Kidney Found"},{"key":"10.1016\/j.clinthera.2021.01.013_bib22","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1053\/j.ajkd.2014.03.003","article-title":"Canadian Society of Nephrology commentary on the 2012 KDIGO clinical practice guideline for the management of blood pressure in CKD","volume":"63","author":"Ruzicka","year":"2014","journal-title":"Am J kidney Dis: official J Natl Kidney Found"},{"key":"10.1016\/j.clinthera.2021.01.013_bib23","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/ndt\/gft321","volume":"29","author":"Verbeke","year":"2014","journal-title":"Nephrol Dialysis, Transplantation: Official Publication Eur Dial Transpl Assoc - Eur Ren Assoc"},{"key":"10.1016\/j.clinthera.2021.01.013_bib24","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European society of Cardiology (ESC) and the European society of hypertension (ESH)","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinthera.2021.01.013_bib25","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.trre.2018.06.002","article-title":"Hypertension guidelines: how do they apply to kidney transplant recipients","volume":"32","author":"Aziz","year":"2018","journal-title":"Transplant Rev (Orlando, Fla)"},{"key":"10.1016\/j.clinthera.2021.01.013_bib26","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1053\/j.ackd.2015.01.002","article-title":"Hypertension, living kidney donors, and transplantation: where are we today?","volume":"22","author":"Rossi","year":"2015","journal-title":"Adv chronic kidney Dis"},{"issue":"9308","key":"10.1016\/j.clinthera.2021.01.013_bib27","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(02)07875-3","article-title":"European Tacrolimus vs Ciclosporin Microemulsion Renal Transplantation Study Group. Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomised multicentre study","volume":"359","author":"Margreiter","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2021.01.013_bib28","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1093\/ndt\/gfn004","article-title":"European Tacrolimus versus Ciclosporin Microemulsion Renal Transplantation Study Group. Efficacy and safety of tacrolimus compared with ciclosporin A in renal transplantation: three-year observational results","volume":"23","author":"Kr\u00e4mer","year":"2008","journal-title":"Nephrol Dial Transpl"},{"key":"10.1016\/j.clinthera.2021.01.013_bib29","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.4103\/1319-2442.248292","article-title":"Comparison of tacrolimus and cyclosporine for immunosuppression after renal transplantation: an updated systematic review and meta-analysis","volume":"29","author":"Azarfar","year":"2018","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2021.01.013_bib30","doi-asserted-by":"crossref","first-page":"188","DOI":"10.6002\/ect.MESOT2018.P59","article-title":"Relationship between peripheral-central blood pressure and cardiac-renal damage in kidney transplant recipients","volume":"17","author":"Firat","year":"2019","journal-title":"Exp Clin Transplant : official J Middle East Soc Organ Transplant"},{"key":"10.1016\/j.clinthera.2021.01.013_bib31","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.transproceed.2017.11.052","article-title":"Changes in antihypertensive therapy after renal transplantation","volume":"50","author":"Villanego","year":"2018","journal-title":"Transplant Proc"},{"key":"10.1016\/j.clinthera.2021.01.013_bib32","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1097\/TP.0000000000001023","article-title":"Nocturnal hypertension and altered night-day BP profile and atherosclerosis in renal transplant patients","volume":"100","author":"Mallamaci","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.clinthera.2021.01.013_bib33","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2021.01.013_bib34","series-title":"Hypertension in Adults: Diagnosis and Management","year":"2019"},{"key":"10.1016\/j.clinthera.2021.01.013_bib35","first-page":"155","article-title":"Renin-angiotensin system inhibitors in kidney transplantation: a benefit-risk assessment","volume":"30","author":"Ponticelli","year":"2017","journal-title":"J\u00a0Nephrol"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291821000175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291821000175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:54:39Z","timestamp":1758963279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291821000175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0149291821000175"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2021.01.013","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Frequency and Patterns of Prescribing Antihypertensive Agents in Outpatient Kidney Transplant Recipients Among Six Cities in China from 2011 to 2018","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2021.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}